| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $493.7M | -5.3% |
| R&D Expense | $191.4M | -14.1% |
| SG&A Expense | $218.1M | -6.6% |
| Operating Income | -$87.1M | +32.8% |
| Interest Expense | $3.0M | +0.3% |
| Pre-tax Income | $11.6M | +108.9% |
| Income Tax | $12.4M | +24.0% |
| Net Income | -$14.0M | +89.7% |
| EPS (Basic) | -$0.31 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $130.6M | -8.1% |
| Accounts Receivable | $58.7M | +4.9% |
| Current Assets | $304.9M | -3.8% |
| Total Assets | $667.8M | -0.9% |
| Current Liabilities | $185.3M | +12.3% |
| Long-term Debt | $27.7M | -44.6% |
| Total Liabilities | $238.7M | -16.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$55.3M | — |
| Capital Expenditures | $5.0M | -60.4% |
| Investing Cash Flow | $50.8M | +492.9% |
| Financing Cash Flow | -$19.4M | -374.4% |
| Free Cash Flow | -$60.4M | -376.0% |
| +90.3% |
| EPS (Diluted) | -$0.31 | +90.3% |
| Stockholders' Equity |
| $429.1M |
| +6.1% |